MedDataX Logo

Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults.

NCT ID: NCT00383916

Last Updated: 2007-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Study Classification

INTERVENTIONAL

Study Start Date

2006-10-31

Study Completion Date

2006-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study comparing 2 different investigational formulations of pantoprazole in healthy adults.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study

NCT01654705

Healthy
COMPLETED NA

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

NCT01654718

Healthy
COMPLETED NA

Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fasting Conditions

NCT01418417

Healthy
COMPLETED PHASE1

Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition

NCT01283919

Fasting
COMPLETED PHASE1

Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition

NCT01283932

FED
COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

open-label, single-dose, randomized, 2-period, 2-sequence, crossover, inpatient bioequivalence study

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Subjects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pantoprazole

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women aged 18 to 50 years.
* Healthy as determined by the investigator.

Exclusion Criteria

* History or active presence of clinically important medical disease.
* History of drug or alcohol abuse.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Monitor

Role: STUDY_DIRECTOR

Wyeth is now a wholly owned subsidiary of Pfizer

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3001B1-119

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fed Conditions
NCT01418443 COMPLETED PHASE1
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers
NCT06552624 COMPLETED NA
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers
NCT06098742 RECRUITING NA
Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions
NCT01131702 COMPLETED PHASE1
Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions
NCT00829530 COMPLETED PHASE1
A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)
NCT02529787 COMPLETED PHASE1
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions
NCT01499771 COMPLETED PHASE1
Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions
NCT00803192 COMPLETED PHASE1
Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions
NCT00776139 COMPLETED NA
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
NCT06507904 NOT_YET_RECRUITING PHASE1
Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions
NCT00865176 COMPLETED PHASE1
Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions
NCT00802828 COMPLETED PHASE1
Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
NCT00828321 COMPLETED PHASE1
A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144)
NCT00945750 COMPLETED PHASE1
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions
NCT00618254 COMPLETED NA
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions
NCT01170169 COMPLETED PHASE1
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.
NCT01499758 COMPLETED PHASE1
Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions
NCT00776022 COMPLETED NA
Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions
NCT00803764 COMPLETED PHASE1
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition
NCT01170182 COMPLETED PHASE1
To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
NCT00946725 COMPLETED PHASE1
A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:
NCT07201584 RECRUITING PHASE1
Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition
NCT01603134 COMPLETED PHASE1
Comparative Bioavailability Study of Lisinopril Tablets, 10 mg
NCT01375244 COMPLETED PHASE1
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fed Conditions
NCT01990586 COMPLETED PHASE1